Wells Fargo raised the firm’s price target on HCA Healthcare (HCA) to $412 from $375 and keeps an Equal Weight rating on the shares. The firm is updating estimates and price targets in the space ahead of Q3 2025 results. Notability, Wells now assumes extension of enhanced subsidies is likely.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
- Nutex Health appoints Wesley Bamburg as COO
- HCA Healthcare price target raised to $445 from $390 at Barclays
- HCA Healthcare price target raised to $430 from $375 at BofA
- HCA Healthcare price target raised to $417 from $404 at Bernstein
- Balanced Outlook on HCA Healthcare: Strong Margins Amid Slower Growth and Policy Risks